Skip to content
Search

Latest Stories

UKHSA expands notifiable disease list: Medical professionals must report 8 more diseases

Under the new requirements, labs in England will also be required to report 10 additional pathogens to boost surveillance.

UKHSA expands notifiable disease and pathogen reporting requirements

Robust disease surveillance is vital for effective public health response, says UKHSA

Getty Images

The UK Health Security Agency (UKHSA) has updated Health Protection Notification Regulations (HPNR) requirements, expanding the list of notifiable diseases and pathogens.

From 6 April 2025, registered medical professionals will be required to report suspected cases of 8 additional conditions, besides existing infections.


These include:

  • Middle East respiratory syndrome (MERS)
  • Influenza of zoonotic origin
  • Chickenpox (varicella)
  • Congenital syphilis
  • Neonatal herpes
  • Acute flaccid paralysis (AFP) or acute flaccid myelitis (AFM)
  • Disseminated gonococcal infection (DGI)
  • Creutzfeldt-Jakob disease (CJD)

Under the new requirements, diagnostic laboratories testing human samples in England will also be required to report 10 additional pathogens, including:

  • Middle East respiratory syndrome coronavirus (MERS-CoV)
  • Non-human influenza A subtypes
  • Norovirus
  • Echinococcus spp
  • Tick-borne encephalitis virus (TBEV)
  • Toxoplasma (congenital toxoplasmosis)
  • Trichinella spp
  • Yersinia spp
  • Respiratory syncytial virus (RSV)
  • Candidozyma auris

These changes follow a public consultation and joint assessment by UKHSA and the Department of Health and Social Care (DHSC) to strengthen surveillance of both existing and emerging infectious diseases and improve outbreak response capabilities.

“These expanded reporting requirements will strengthen our ability to detect and respond to infectious disease outbreaks quickly and effectively,” said Dr William Welfare, UKHSA director of health protection operations.

He emphasised that robust disease surveillance is vital for effective public health response as the data gathered through this system helps develop and implement timely public health interventions.

“When registered medical practitioners report certain diseases, UKHSA’s Health Protection Teams will take action.”

“This might include giving antibiotics to people who’ve been in contact with patients, offering vaccines, or advising people to self-isolate. For other diseases, the reports help UKHSA track how illnesses spread and how effective interventions are,” he added.

To streamline the reporting process, UKHSA recently launched an electronic NOIDs system, enabling healthcare professionals to submit notifications online.

This digital system is faster than the old paper-based method, helping UKHSA respond more quickly to health threats and reducing the burden of reporting for healthcare professionals.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less